PRTA Q2 2022 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-97.8% YoY

Gross Profit

-$30M-2306.2% margin

Operating Income

-$43M-3293.4% margin

Net Income

-$41M-3143.6% margin

EPS (Diluted)

$-0.88

QoQ Revenue Growth

+13.8%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$550M

Total Liabilities

$142M

Stockholders' Equity

$407M

Cash & Equivalents

$509M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$60M	-97.8%
Gross Profit	-$30M	$39M	-177.6%
Operating Income	-$43M	$28M	-254.6%
Net Income	-$41M	$28M	-249.2%

Revenue Segments

US Rights and Global Rights

$85M78%

Collaboration Revenue, US Development Services

$23M21%

Collaboration

$1M1%